Skip to main content

Advertisement

Table 1 The clinic- pathological features of patients with pituitary adenoma

From: Up-regulation of 15-lipoxygenase enzymes and products in functional and non-functional pituitary adenomas

Parameter Groups Pituitary adenoma (n = 55) Non-Functional pituitary adenoma (n = 25) Functional pituitary adenoma (n = 30) Acromegaly (n = 17) Cushing (n = 13)
Age (Years) 20–40 27 (49.09%) 11 (44%) 15 (50%) 9 (52.94%) 7 (53.84%)
40–60 17 (30.9%) 7 (28%) 10 (33.33%) 5 (29.41%)
60≤ 11 (20%) 7 (28%) 5 (16.66%) 3 (17.64%) 5 (38.46%)
1 (7.69%)
Gender Female 26 (47.27%) 9 (36%) 19 (63.33%) 9 (52.94%) 8 (61.53%)
Male 29 (52.72%) 16 (64%)
    11 (36.66%) 8 (47.05%) 5 (38.46%)
Tumor invasiveness Invasive 25 (45.45%) 10 (40%) 13 (43.43%) 9 (52.94%) 4 (30.76%)
Non- Invasive 30 (54.54%) 15 (60%) 17 (56.56%) 8 (47.05%) 9 (69.23%)
Tumor size Micro-Adenoma 11 (20%) 0 13 (43.43%) 5 (29.41%) 8 (61.53%)
Macro-Adenoma 44 (80%) 25 (100%) 17 (56.56%) 12 (70.58%) 5 (38.46%)